Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Data on almost 17 million adults nationwide showed the obesity rate -- which has been rising for years -- fell from 46.2% of ...

With childhood obesity on the rise, Professor Chris Whitty calls for urgent action to reduce health inequalities across the ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will ...

Obesity dipped slightly in U.S. adults last year, research found — the first time in more than a decade that the country has ...

Obesity and body mass index in the U.S. have decreased for the first time in more than a decade.

The mean body mass index (BMI) and the prevalence of obesity both dropped in 2023 for the first time in more than a decade.

Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.

New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...

The study builds on evidence from trials like RALES and EMPHASIS-HF, both of which suggested that the benefit of MRAs may be ...